Recalls / Generics / Octreotide Acetate
Octreotide Acetate
4 FDA drug recalls involving generic “Octreotide Acetate” — 1 Class I.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2026-03-17 | Class II | Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 20 mg, Single-dose 8 mL vial, Rx | Teva Pharmaceuticals USA, Inc |
| 2026-03-17 | Class II | Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 10 mg, Single-dose 8 mL vial, Rx | Teva Pharmaceuticals USA, Inc |
| 2026-03-17 | Class II | Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 30 mg, Single-dose 8 mL vial, Rx | Teva Pharmaceuticals USA, Inc |
| 2022-10-07 | Class I | Octreotide Acetate Injection 500 mcg/mL, 10 x 1 mL Single-Dose Unit-of-Use Syringes, For Subcutaneous or Intra | Viatris Inc |